Lannett traded at $0.58 this Thursday June 30th, decreasing $0.01 or 1.66 percent since the previous trading session. Looking back, over the last four weeks, Lannett lost 11.58 percent. Over the last 12 months, its price fell by 87.11 percent. Looking ahead, we forecast Lannett to be priced at 0.56 by the end of this quarter and at 0.52 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 153.16 -0.98 -0.64% 34.05%
AmerisourceBergen 141.48 -2.10 -1.46% 21.50%
Aurora Cannabis Inc 1.70 -0.06 -3.41% -83.98%
ANI Pharmaceuticals 29.67 1.81 6.50% -17.56%
Cardinal Health 52.27 -1.42 -2.64% -9.79%
Corcept Therapeutics 23.78 -0.96 -3.88% 5.55%
Depomed 2.95 0.10 3.51% 92.81%
Endo International 0.47 -0.06 -10.89% -90.20%
Knight Therapeutics Inc 5.34 -0.01 -0.19% 1.52%
Jazz Pharmaceuticals 156.01 -0.35 -0.22% -13.89%
Lannett 0.58 -0.01 -1.66% -87.11%
Ligand Pharmaceuticals 89.22 0.74 0.84% -34.36%
McKesson 326.21 -1.85 -0.56% 69.31%
Nektar Therapeutics 3.80 -0.16 -4.04% -78.31%
Novartis 84.53 -0.24 -0.28% -7.77%
Omeros 2.75 0.09 3.38% -82.44%
Phibro Animal Health 19.13 -0.06 -0.31% -36.25%
Prestige Brands 58.80 1.86 3.27% 11.34%
Pacira 58.30 -0.33 -0.56% -2.80%
Pfizer 52.43 1.49 2.93% 32.53%
Perrigo 40.57 -0.40 -0.98% -13.14%
Supernus Pharmaceuticals 28.92 0.42 1.47% -7.87%
Teva Pharmaceutical Industries Ltd 2,670.00 -83.00 -3.01% -18.10%
Canopy Growth Corp 3.66 -0.83 -18.49% -87.25%
Zoetis 171.89 -2.03 -1.17% -9.19%

Indexes Price Day Year
US2000 1708 -11.38 -0.66% -26.68%

Lannett
Lannett Company, Inc. is a developer, manufacturer, marketer, and distributer of generic versions of brand pharmaceutical products for a range of medical indications. The Company's products include Fluphenazine Tablets, which are used for the management of manifestations of psychotic disorders; Posaconazole DR Tablets, which are used to prevent fungal infections in people; Verapamil SR tablets are a calcium channel blocker used in the treatment of high blood pressure, arrhythmia and angina; Methylphenidate CD Capsules used for the treatment of Attention Deficit Hyperactivity Disorder; Omeprazole Capsules, which is indicated for the treatment of certain diseases of the esophagus and stomach ulcers; Pantoprazole Sodium DR Tablets, which is a proton pump inhibitor, indicated for the treatment of certain diseases of the esophagus and pathological hypersecretory conditions; and Sumatriptan Nasal Spray, which is indicated for the acute treatment of migraine attacks.